Skip to content
Chat on WhatsApp
Semaglutide

Incretin-Pathway Peptides

Semaglutide

A GLP-1 analogue with a 31-amino-acid backbone and a fatty di-acid side chain, sealed as a lyophilized vial for receptor research.

  • 31-amino-acid GLP-1 analogue backbone
  • C18 fatty di-acid side chain
  • Sealed vials, 5mg to 50mg

Research use only

Semaglutide is a GLP-1 analogue built on a 31-amino-acid peptide backbone, with a C18 fatty di-acid side chain attached at a defined position. It is one of the anchor entries in the incretin-pathway section of this catalog.

Structural modifications at specific positions in the sequence make this peptide a useful reference material in peptide engineering work and receptor-focused laboratory studies. The molecular weight and formula shown on this page describe the peptide as supplied in lyophilized form.

Vials are sealed after freeze-drying and available across a wide size range, from 5mg through 50mg. Batch documentation for a specific lot is confirmed by inquiry.

Purity≥99% by HPLC
CAS number910463-68-2
Molecular weight4113.58 g/mol
Molecular formulaC187H291N45O59
Material class31-amino-acid peptide
AppearanceWhite lyophilized powder
Available vial sizes5mg · 10mg · 15mg · 20mg · 50mg
DocumentationBatch documentation confirmed on request

← Back to the catalog